AU2001288847A1 - Conformationally constrained labeled peptides for imaging and therapy - Google Patents
Conformationally constrained labeled peptides for imaging and therapyInfo
- Publication number
- AU2001288847A1 AU2001288847A1 AU2001288847A AU8884701A AU2001288847A1 AU 2001288847 A1 AU2001288847 A1 AU 2001288847A1 AU 2001288847 A AU2001288847 A AU 2001288847A AU 8884701 A AU8884701 A AU 8884701A AU 2001288847 A1 AU2001288847 A1 AU 2001288847A1
- Authority
- AU
- Australia
- Prior art keywords
- therapy
- imaging
- labeled peptides
- conformationally constrained
- conformationally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/6425—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a receptor, e.g. CD4, a cell surface antigen, i.e. not a peptide ligand targeting the antigen, or a cell surface determinant, i.e. a part of the surface of a cell
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/083—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being octreotide or a somatostatin-receptor-binding peptide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23078900P | 2000-09-07 | 2000-09-07 | |
US60/230,789 | 2000-09-07 | ||
PCT/US2001/027708 WO2002020610A2 (en) | 2000-09-07 | 2001-09-07 | Conformationally constrained labeled peptides for imaging and therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001288847A1 true AU2001288847A1 (en) | 2002-03-22 |
Family
ID=22866588
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001288847A Abandoned AU2001288847A1 (en) | 2000-09-07 | 2001-09-07 | Conformationally constrained labeled peptides for imaging and therapy |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001288847A1 (en) |
WO (1) | WO2002020610A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ530156A (en) * | 2001-07-10 | 2007-04-27 | Ge Healthcare As | Peptide-based compounds for targeting integrin receptors for use as diagnostic imaging agents |
IL148921A0 (en) * | 2002-03-26 | 2002-09-12 | Peptor Ltd | Photo active backbone cyclized somatostatin analogs for optical imaging and photodynamic therapy |
US6861236B2 (en) | 2002-05-24 | 2005-03-01 | Applied Nanosystems B.V. | Export and modification of (poly)peptides in the lantibiotic way |
GB0317815D0 (en) | 2003-07-30 | 2003-09-03 | Amersham Health As | Imaging agents |
NO20034350D0 (en) * | 2003-09-29 | 2003-09-29 | Amersham Health As | Optical imaging of colorectal cancer |
EP1729823B1 (en) | 2004-03-04 | 2009-11-04 | GE Healthcare AS | Conjugates of angiotensin peptidic analogues and chelating agents for diagnosis and therapy |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6117974A (en) * | 1991-10-02 | 2000-09-12 | Peptor Limited | Libraries of backbone-cyclized peptidomimetics |
US6355613B1 (en) * | 1996-07-31 | 2002-03-12 | Peptor Limited | Conformationally constrained backbone cyclized somatostatin analogs |
-
2001
- 2001-09-07 AU AU2001288847A patent/AU2001288847A1/en not_active Abandoned
- 2001-09-07 WO PCT/US2001/027708 patent/WO2002020610A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2002020610A2 (en) | 2002-03-14 |
WO2002020610A3 (en) | 2002-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002245629A1 (en) | Stabilized therapeutic and imaging agents | |
AU2001243710A1 (en) | Imaging stretcher | |
AUPQ899700A0 (en) | Probiotic recolonisation therapy | |
AU2001252504A1 (en) | Combined impedance imaging and mammography | |
AU4082801A (en) | Imaging apparatus | |
AU4248600A (en) | Combined imaging and pdt delivery system | |
AU2001251114A1 (en) | Enhancing contrast in biological imaging | |
AU2001278319A1 (en) | Amyloid targeting imaging agents and uses thereof | |
AU6894700A (en) | Therapeutic polypeptides and methods for using same | |
AU2002255952A1 (en) | Short bioactive peptides and methods for their use | |
AU2001250889A1 (en) | Patient weighing apparatus | |
AU2001287890A1 (en) | Radiotherapy apparatus and collimator set therefor | |
AU2001259837A1 (en) | Therapeutic pore-forming peptides | |
AU2000268695A1 (en) | Imaging apparatus | |
AU2002363944A1 (en) | Alpha-fetoprotein peptides and uses for imaging | |
AU2001286721A1 (en) | Human interleukin-four induced protein | |
AU2001229439A1 (en) | Bioconjugates and uses thereof | |
AU4776800A (en) | Acetylcholinesterase-derived peptides and uses thereof | |
AU2002243314A1 (en) | Immunogenic cancer peptides and uses thereof | |
AU2001288847A1 (en) | Conformationally constrained labeled peptides for imaging and therapy | |
AU5836700A (en) | Peptides for therapeutic use | |
AU2001249906A1 (en) | Human transporters and ion channels | |
IL147731A0 (en) | Peptide pharmaceutical formulations | |
AU2001249608A1 (en) | Bladder cancer-specific peptides for diagnosis and therapy | |
AU3774000A (en) | Conformationally constrained peptides |